Related Experiment Video
Updated: Jan 15, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Risks and consequences of TB and its prevention in cost-utility analyses among immigrants: a systematic review
S D Robayo1, C M Tansey2, K Romanowski3,4
1Department of Experimental Medicine, McGill University, Montreal, Canada.
Background:
In low-TB incidence countries, foreign-born populations bear a disproportionate share of the TB burden. Cost-utility analyses of TB preventive treatment (TPT) programs among immigrants, however, have yielded divergent conclusions. We conducted a systematic review to evaluate how studies have considered the risks and consequences of TB disease and TPT.
Methods:
We searched PubMed and Embase for studies published from 1st January 2004 to 25th March 2025. We included modeling studies measuring health utility with quality-adjusted life years (QALYs) and evaluated TPT among immigrants to low TB incidence countries. Using a narrative synthesis, we examined how studies considered risks and consequences of TB disease and TPT and their impacts on health utility.
Results:
Of the 5,142 records screened, 14 studies met the inclusion criteria. Major adverse events (AEs) were the most frequently considered consequence of TPT with estimated risk ranging from 0% to 6% and mean associated annual disutility from major AEs was 0.017 QALYs, which varied substantially (coefficient of variation [CV)]: 1.2). All studies considered health disutility due to TB disease, with annual disutility ranging from 0.04 to 0.2 (mean: 0.11, CV: 0.4).
Conclusions:
There is wide variation in how risks and consequences of TPT and TB disease are considered in studies evaluating TB infection treatment programs.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...